Therapeutics News and Research

RSS
Patients new to chronic disease medication face risk of medication discontinuation, finds study

Patients new to chronic disease medication face risk of medication discontinuation, finds study

Pre-clinical study data of Stemline Therapeutics' IL-3R targeting agents to be presented at the ASH meeting

Pre-clinical study data of Stemline Therapeutics' IL-3R targeting agents to be presented at the ASH meeting

Preclinical data of Curis' HSP 90 inhibitor published

Preclinical data of Curis' HSP 90 inhibitor published

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

Santaris Pharma's LNA technology based microRNA-targeted therapy holds promise for HCV

Santaris Pharma's LNA technology based microRNA-targeted therapy holds promise for HCV

InVivo Therapeutics files an Investigational Device Exemption application with the FDA

InVivo Therapeutics files an Investigational Device Exemption application with the FDA

StemCells welcomes NIH's approval of the first 13 human embryonic stem cell lines for research

StemCells welcomes NIH's approval of the first 13 human embryonic stem cell lines for research

Osseon Therapeutics' Osseoflex and Osseoflex DR systems receive Canadian Medical Device Licenses

Osseon Therapeutics' Osseoflex and Osseoflex DR systems receive Canadian Medical Device Licenses

Kyto advancing with a program for humanization of the mAbTCR23 antibody

Kyto advancing with a program for humanization of the mAbTCR23 antibody

Pfizer announces a $9M cancer research collaboration in British Columbia

Pfizer announces a $9M cancer research collaboration in British Columbia

Guidepoint Global launches Sleep Apnea Tracker

Guidepoint Global launches Sleep Apnea Tracker

Shorter amyloid fibres more toxic than longer counterparts, says study

Shorter amyloid fibres more toxic than longer counterparts, says study

Alkermes licenses Medifusion technology to develop TNF receptor-Fc fusion protein

Alkermes licenses Medifusion technology to develop TNF receptor-Fc fusion protein

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

iCo Therapeutics to present an overview of its iCo-007 VEGF "+" agent at the ISOPT conference

iCo Therapeutics to present an overview of its iCo-007 VEGF "+" agent at the ISOPT conference

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Allos Therapeutics to launch the COMPLETE registry for patients with PTCL

Allos Therapeutics to launch the COMPLETE registry for patients with PTCL

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Study: Stem cells from donor bone marrow may help repair heart damage

Study: Stem cells from donor bone marrow may help repair heart damage

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.